NMRA
Neumora Therapeutics Inc.
$2.09
+$0.02(+0.97%)
30
Overall
60
Value
10
Tech
21
Quality
Market Cap
$432.76M
Volume
618.11K
52W Range
$0.61 - $11.57
Target Price
$9.17
Key Metrics Overview
| Market Cap | $432.76M | P/E Ratio | N/A |
| 52W High | $11.57 | 52W Low | $0.61 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 13.5% |
| Overall Score | 30 | Value Score | 60 |
| Quality Score | 21 | Technical Score | 10 |
Growth Analysis
| EPS Current Est | $-1.44 | EPS Next Est | $-0.99 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $2.09 | +1.0% | 618.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW